![Callum Meikle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Callum Meikle
Director/Board Member at Scottish Ballet
Callum Meikle active positions
Companies | Position | Start | End |
---|---|---|---|
Scottish Ballet
![]() Scottish Ballet Movies/EntertainmentConsumer Services Scottish Ballet operates as a dance company. The company was founded by Peter Darrell and Elizabeth West in 1957 and is headquartered in Glasgow, the United Kingdom. | Director/Board Member | - | - |
Pleco Therapeutics BV
![]() Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Director/Board Member | - | - |
Career history of Callum Meikle
Statistics
International
United Kingdom | 2 |
Netherlands | 2 |
Operational
Director/Board Member | 2 |
Sectoral
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Scottish Ballet
![]() Scottish Ballet Movies/EntertainmentConsumer Services Scottish Ballet operates as a dance company. The company was founded by Peter Darrell and Elizabeth West in 1957 and is headquartered in Glasgow, the United Kingdom. | Consumer Services |
Pleco Therapeutics BV
![]() Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Commercial Services |
- Stock Market
- Insiders
- Callum Meikle
- Experience